IA

Irfan Ahmed Khan

Active Director Director DIN 10628773
DIN 10628773 First appointment May 2024 Primary industry Biotechnology
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Irfan Ahmed Khan

Data last updated:

Irfan Ahmed Khan is a Director at Quremark Biopharma Private Limited (since 2024). The company operates in Biotechnology.

DIN 10628773
Primary Designation Director
Industry Biotechnology
First Appointment 15 May 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Quremark Biopharma Private Limited U46497GJ2024PTC151519
Director15 May 20242024Active

Board colleagues of Irfan Ahmed Khan

NameDINCompanyDesignation
Manoj Khatri08569678Quremark Biopharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Quremark Biopharma Private Limited
Premium access

Shareholding and investment profile for Irfan Ahmed Khan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Irfan Ahmed Khan

Irfan Ahmed Khan currently holds 1 directorship: Quremark Biopharma Private Limited (Director, since 15 May 2024).

Irfan Ahmed Khan was first appointed on 15 May 2024 as Director at Quremark Biopharma Private Limited.

The current boards of Irfan Ahmed Khan's companies include Manoj Khatri (Quremark Biopharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available